Asia On The Move: China FDA Reorganizes, Appoints Deputy Commissioners
This article was originally published in PharmAsia News
China’s Food and Drug Administration has appointed four deputy commissioners and two general directors of food and drug safety. Personnel changes also take place at Lilly, Novartis and big pharma’s trade association in China.
You may also be interested in...
A regulatory pathway set up in China post-SARS is under stress test in the latest coronavirus outbreak, while emergency measures adopted by the country's regulator mean it’s much less burdensome to obtain approvals than before.
In a drastic move, China sends top physicians from around the country to Wuhan, finally allows a WHO expert delegation to visit hospitals in the outbreak's epicenter and welcomes foreign experts.